Two drugs appear to delay cancer progression News Chief Both drugs, pertuzumab from Genentech and everolimus from Novartis, also showed signs that they could prolong lives, though researchers said it was too early to say that definitively. Results of the studies, which were sponsored by the companies, ... |
